Clinical Trials Browser

OTHER × Vaccines × Head & Neck × Clear all

NCT03946358 2024-12-20

VolATIL

Phase 2 Completed

GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

NCT01094405 2021-07-28

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Phase 2 Completed

Nasopharyngeal Neoplasms, Recurrence, Epstein-Barr Virus Infections